Literature DB >> 15582390

The sema domain.

Ermanno Gherardi1, Christopher A Love, Robert M Esnouf, E Yvonne Jones.   

Abstract

The sema domain was first defined from sequence by Kolodkin and colleagues in the early 1990s, and constitutes the distinctive structural and functional element of semaphorins, their plexin receptors and the receptor tyrosine kinases MET and RON, three protein families with major roles in development, tissue regeneration and cancer. Recently determined crystal structures of two semaphorins (SEMA3A and SEMA4D) and the MET receptor have shown that the sema domain consists of a highly conserved variant form of the seven-blade beta-propeller fold. The structures, however, also suggest differences between these families with respect to the mode of dimerisation and the regions of the domain involved in ligand-receptor interactions. This reflects the considerable plasticity and adaptation of the sema domain in order to meet different binding requirements, properties that may underlie the vast array of ligand-receptor specificities and functions of the semaphorin superfamily.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582390     DOI: 10.1016/j.sbi.2004.10.010

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  56 in total

1.  Isolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration.

Authors:  Zeynep Gunes; Adriana Zucconi; Mario Cioce; Annalisa Meola; Monica Pezzanera; Stefano Acali; Immacolata Zampaglione; Valeria De Pratti; Luca Bova; Fabio Talamo; Anna Demartis; Paolo Monaci; Nicola La Monica; Gennaro Ciliberto; Alessandra Vitelli
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

Review 2.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 3.  Semaphorin3A: A potential therapeutic tool in immune-mediated diseases.

Authors:  Zahava Vadasz; Elias Toubi
Journal:  Eur J Rheumatol       Date:  2017-12-07

4.  Transcriptome and protein domain analyses in Aplysia nervous system with evolutionary implications.

Authors:  Yong-Seok Lee; Tae-Hyung Kim; Sun-Lim Choi; Sunghoon Lee; Jong Bhak; Bong-Kiun Kaang
Journal:  Commun Integr Biol       Date:  2009-07

Review 5.  Semaphorin 5A mediated cellular navigation: connecting nervous system and cancer.

Authors:  Abhilasha Purohit; Anguraj Sadanandam; Pavan Myneni; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2014-09-28

6.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

Review 7.  Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive.

Authors:  Mélanie Franco; Luca Tamagnone
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

8.  Genetic interaction of Neuroglian and Semaphorin1a during guidance and synapse formation.

Authors:  Tanja A Godenschwege; Rodney K Murphey
Journal:  J Neurogenet       Date:  2008-12-01       Impact factor: 1.250

9.  Semaphorin 5B mediates synapse elimination in hippocampal neurons.

Authors:  Timothy P O'Connor; Katie Cockburn; Wenyan Wang; Lucia Tapia; Erin Currie; Shernaz X Bamji
Journal:  Neural Dev       Date:  2009-05-23       Impact factor: 3.842

10.  Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies.

Authors:  Ilse Roodink; Kiek Verrijp; Jos Raats; William P J Leenders
Journal:  BMC Cancer       Date:  2009-08-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.